This California family thought a trip to Disneyland would be the perfect way to celebrate their new baby. Unfortunately, the Loops came home with much more than the happy memories they had hoped for.
Dr. Peter A. Fotinakes has made it his life’s commitment to treat sleep apnea, which is his passion.
Narcolepsy is often misdiagnosed and frequently misunderstood. Most individuals experience symptoms for an average of three to five years before receiving an accurate diagnosis, although 10- to 15-year delays are not uncommon.
FFF Enterprises takes a “safety first” approach when it comes to business best practices for distributing fragile biologics and transport-sensitive vaccines.
According to the National Institutes of Health, approximately 7.7 million American adults age 18 and older suffer symptoms of post-traumatic stress disorder (PTSD). Thankfully, emerging treatments are providing relief and recovery, even in the most severe cases.
Dr. Alina Suris has developed a cellular therapy to treat PTSD for which she has won a George Winokur Research Award.
As president and CEO of TraceLink,Inc., Shabbir Dahod leads a visionary team that helps companies meet the complex requirements of the Drug Supply Chain Security Act.
In this annual plasma-themed issue of BioSupply Trends Quarterly, we take a critical look at the current plasma market, especially issues of supply and demand.
